“Wound Debridement Market is expected to Reach $1.92 Billion By 2029”, says Visiongain report

08 January 2020
Pharma

Visiongain’s new report the Wound Debridement Market Report 2019-2029: Forecasts by Product (Gels, Ointments & Creams, Surgical Devices, Medical Gauzes, Mechanical Debridement Pads, Ultrasonic Devices, Others), by Wound Type (Venous Leg Ulcers, Diabetic Foot Ulcers, Pressure Ulcers, Surgical & Traumatic Wounds, Burns, Others), by Method (Autolytic Methods, Enzymatic Methods, Surgical Methods, Mechanical Methods, Others), by End User (Hospitals, Clinics, Others), plus analysis of leading companies operating in the global wound debridement market.

Increasing prevalence of diabetes and associated wounds, rising aging population in developed as well as developing economies, increasing incidences if burn injuries and increasing awareness regarding wound care management are expected to spur global wound debridement market over the forecast period. In 2019, the global wound debridement market was valued at $830 million and is expected to reach $1.92 billion by 2029 at a healthy growth rate of 8.7%.

Growing incidences of diabetes, pressure ulcers, and other chronic diseases are encouraged wound care management providers over the past few years and the trend is expected to continue over the coming years. According to the World Health Organization, in 1980, the number of people diagnosed with diabetes was nearly 108 million and this figure has increased to more than 450 million in 2018. Additionally, a hectic lifestyle, increasing working hours, and an unhealthy diet has resulted in increased prevalence of diabetes in the young population. For instance, according to the World Health Organization, the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to more than 9% in 2018.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

Read

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever